Intermediate-term follow-up after transmyocardial laser revascularisation

Area of Science:

• Cardiology
• Minimally Invasive Surgery
• Cardiovascular Interventions

Background:

• Severe diffuse coronary artery disease (CAD) often presents challenges for conventional therapies.
• Transmyocardial laser revascularization (TLR) has emerged as a potential treatment option for refractory CAD.
• Evaluating the efficacy of TLR in patients with limited therapeutic alternatives is crucial.

Purpose of the Study:

• To assess the clinical outcomes of isolated transmyocardial laser revascularization (TLR) in patients with severe coronary artery disease.
• To evaluate the impact of TLR on angina symptoms, exercise capacity, and left ventricular function.
• To determine the long-term benefits of TLR in improving quality of life for eligible patients.

Main Methods:

• A cohort of 102 patients underwent isolated transmyocardial laser revascularization between December 1994 and November 1997.
• Patient outcomes were assessed by monitoring angina class, exercise treadmill test workload, and left ventricle ejection fraction (MUGA).
• Follow-up assessments were conducted at one year post-procedure to evaluate treatment efficacy.

Main Results:

• Angina class significantly improved from 2.56 +/- 0.8 pre-operatively to 0.8 +/- 0.9 at one year, with 54% of patients becoming angina-free.
• Exercise treadmill test workload increased from 3.6 +/- 1.7 METS to 6.0 +/- 3.4 METS (p < 0.005) at one year.
• Left ventricle ejection fraction showed a non-significant slight decrease at one year post-TLR.

Conclusions:

• Transmyocardial laser revascularization provides significant symptomatic benefit for patients with severe, refractory coronary artery disease.
• The procedure objectively improves exercise tolerance and enhances the quality of life at 12 months post-intervention.
• TLR represents a viable therapeutic option for select patients with diffuse coronary artery disease unresponsive to conventional treatments.